These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 32433223

  • 1. Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.
    Nakamura N, Muto T, Masuda Y, Numoto S, Kodama S, Miyamoto R, Miyata K, Hayakawa T, Mori H, Kuroyanagi Y, Akaihata M, Iwayama H, Kurahashi H, Shimomura Y, Nagai T, Hori T, Agata H, Okumura A.
    Pediatr Infect Dis J; 2020 Sep; 39(9):857-861. PubMed ID: 32433223
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):78. PubMed ID: 31775782
    [Abstract] [Full Text] [Related]

  • 3. Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease.
    Nakashima Y, Nanishi E, Yamamura K, Uike K, Terashi E, Hirata Y, Nagata H, Morihana E, Tanaka T, Honjo S, Takada H, Ohga S.
    Cytokine; 2019 Feb 27; 114():26-31. PubMed ID: 30583086
    [Abstract] [Full Text] [Related]

  • 4. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y, Chen T, Wen Y, Si F, Wu X, Yang Y.
    BMC Pediatr; 2021 Sep 16; 21(1):406. PubMed ID: 34530763
    [Abstract] [Full Text] [Related]

  • 5. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Sep 16; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 6. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?
    Dominguez SR, Martin B, Heizer H, Jone PN, Tong S, Davidson J, Anderson MS, Glodé MP.
    J Pediatric Infect Dis Soc; 2016 Sep 16; 5(3):297-302. PubMed ID: 26407256
    [Abstract] [Full Text] [Related]

  • 7. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
    Ha KS, Lee J, Lee KC.
    Eur J Pediatr; 2020 Feb 16; 179(2):257-264. PubMed ID: 31713683
    [Abstract] [Full Text] [Related]

  • 8. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
    [Abstract] [Full Text] [Related]

  • 9. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
    Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B.
    Int Immunopharmacol; 2020 Dec 18; 89(Pt A):107037. PubMed ID: 33242833
    [Abstract] [Full Text] [Related]

  • 10. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.
    Niu MM, Jiang Q, Ruan JW, Liu HH, Chen WX, Qiu Z, Fan GZ, Li RX, Wei W, Hu P.
    Clin Exp Med; 2021 Nov 18; 21(4):633-643. PubMed ID: 33839960
    [Abstract] [Full Text] [Related]

  • 11. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 18; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 12. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT, Chang CH, Sun LC, Liu HM, Chang HW, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH.
    J Formos Med Assoc; 2016 May 18; 115(5):350-5. PubMed ID: 25910931
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
    Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
    Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
    [Abstract] [Full Text] [Related]

  • 14. Serum procalcitonin value is useful for predicting severity of Kawasaki disease.
    Yoshikawa H, Nomura Y, Masuda K, Koriya C, Arata M, Hazeki D, Yanagimoto K, Ueno K, Eguchi T, Kawano Y.
    Pediatr Infect Dis J; 2012 May 25; 31(5):523-5. PubMed ID: 22189525
    [Abstract] [Full Text] [Related]

  • 15. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
    Hashimoto I.
    Pediatr Int; 2019 Jul 25; 61(7):641-646. PubMed ID: 31132210
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
    Liu X, Wang L, Zhou K, Shao S, Hua Y, Wu M, Liu L, Wang C.
    Pediatr Rheumatol Online J; 2021 Mar 12; 19(1):24. PubMed ID: 33712036
    [Abstract] [Full Text] [Related]

  • 17. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
    Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
    World J Pediatr; 2020 Dec 12; 16(6):607-613. PubMed ID: 32232677
    [Abstract] [Full Text] [Related]

  • 18. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
    Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J, Borlan S, Gimenez-Roca C, Rivera J, Kawasaki Disease in Catalonia Working Group.
    Rheumatol Int; 2016 Jul 12; 36(7):905-10. PubMed ID: 27215220
    [Abstract] [Full Text] [Related]

  • 19. Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy.
    Yamamoto N, Sato K, Hoshina T, Kojiro M, Kusuhara K.
    Mod Rheumatol; 2015 Jul 12; 25(6):898-902. PubMed ID: 25849851
    [Abstract] [Full Text] [Related]

  • 20. The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model.
    Zhou Y, Wu Y, Yuan C, Yin W, Wang B, Ding Y.
    BMC Pediatr; 2023 Dec 19; 23(1):642. PubMed ID: 38114939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.